β-Glucogallin is used as a novel aldose reductase (ALR2) inhibitor, one of the factors regulating the secondary complications arising from diabetes mellitus.
Synonyms
[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]3,4,5-trihydroxybenzoate; 1-Galloyl-β-D-glucose; 1-(3,4,5-Trihydroxybenzoate) β-D-Glucopyranose;1-Gallate-β-D-glucopyranose; 1-Gallate-β-D-glucose; 1(β)-O-Galloylglucose; 1-Galloyl-β-glucose; 1-Galloylglucose; 1-O-Galloyl-β-D-glucopyranose; 1-O-Galloyl-β-D-glucose; D-Glucose 1-(3,4,5-trihydroxybenzoate); Gallotannin 1; β-D-Glucogallin